ImmunityBio, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ImmunityBio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q3 2024.
  • ImmunityBio, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • ImmunityBio, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$40K, a 218% decline year-over-year.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2023 was -$40K, a 218% decline from 2022.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2022 was $34K, a 278% increase from 2021.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2021 was $9K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$40K $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$40K $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$40K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$40K -$40K -$74K -218% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $34K $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $34K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $34K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $34K $34K +$33K +3300% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $1K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1K $0 -$2K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3K $0 -$6K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $9K $1K +$210K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 -$201K $0 +$1.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.9M $2K -$43K -95.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$1.86M $6K -$12K -66.7% Jan 1, 2021 Mar 31, 2021 10-K 2024-03-19
Q4 2020 -$1.85M -$209K -$138K -194% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$1.71M -$1.7M -$1.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8K $45K +$43K +2150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$51K $18K +$54K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$105K -$71K +$57K +44.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$162K $0 +$128K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$290K $2K +$125K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$415K -$36K +$88K +71% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$503K -$128K +$44K +25.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 -$547K -$128K -$29K -29.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$518K -$123K +$1K +0.81% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$519K -$124K -$26K -26.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$493K -$172K -$23K -15.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-25
Q3 2017 -$470K -$99K -$47K -90.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$423K -$124K +$104K +45.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$527K -$98K +$45K +31.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$572K -$149K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 -$52K -$52K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$228K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$143K -$144K -14400% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q1 2015 $1K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.